98 related articles for article (PubMed ID: 1816490)
1. Transforming growth factor beta (TGF-b1) plays a detrimental role in the progression of experimental Mycobacterium avium infection; in vivo and in vitro evidence.
Denis M; Ghadirian E
Microb Pathog; 1991 Nov; 11(5):367-72. PubMed ID: 1816490
[TBL] [Abstract][Full Text] [Related]
2. The role of macrophage activation and of Bcg-encoded macrophage function(s) in the control of Mycobacterium avium infection in mice.
Appelberg R; Sarmento AM
Clin Exp Immunol; 1990 Jun; 80(3):324-31. PubMed ID: 2115416
[TBL] [Abstract][Full Text] [Related]
3. In vivo modulation of atypical mycobacterial infection: adjuvant therapy increases resistance to Mycobacterium avium by enhancing macrophage effector functions.
Denis M
Cell Immunol; 1991 Apr; 134(1):42-53. PubMed ID: 2013106
[TBL] [Abstract][Full Text] [Related]
4. Mycobacterium avium infection of macrophages results in progressive suppression of interleukin-12 production in vitro and in vivo.
Wagner D; Sangari FJ; Kim S; Petrofsky M; Bermudez LE
J Leukoc Biol; 2002 Jan; 71(1):80-8. PubMed ID: 11781383
[TBL] [Abstract][Full Text] [Related]
5. Production of TNF-alpha, IL-6 and TGF-beta, and expression of receptors for TNF-alpha and IL-6, during murine Mycobacterium avium infection.
Champsi J; Young LS; Bermudez LE
Immunology; 1995 Apr; 84(4):549-54. PubMed ID: 7790028
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-1 is involved in mouse resistance to Mycobacterium avium.
Denis M; Ghadirian E
Infect Immun; 1994 Feb; 62(2):457-61. PubMed ID: 8300206
[TBL] [Abstract][Full Text] [Related]
7. Production of transforming growth factor-beta by Mycobacterium avium-infected human macrophages is associated with unresponsiveness to IFN-gamma.
Bermudez LE
J Immunol; 1993 Mar; 150(5):1838-45. PubMed ID: 8436819
[TBL] [Abstract][Full Text] [Related]
8. The modulating effects of proinflammatory cytokines interferon-gamma (IFN-gamma) and tumour necrosis factor-alpha (TNF-alpha), and immunoregulating cytokines IL-10 and transforming growth factor-beta (TGF-beta), on anti-microbial activity of murine peritoneal macrophages against Mycobacterium avium-intracellulare complex.
Sano C; Sato K; Shimizu T; Kajitani H; Kawauchi H; Tomioka H
Clin Exp Immunol; 1999 Mar; 115(3):435-42. PubMed ID: 10193415
[TBL] [Abstract][Full Text] [Related]
9. TGF-β-mediated sustained ERK1/2 activity promotes the inhibition of intracellular growth of Mycobacterium avium in epithelioid cells surrogates.
L'Abbate C; Cipriano I; Pérez-Hurtado EC; Leão SC; Carneiro CR; Machado J
PLoS One; 2011; 6(6):e21465. PubMed ID: 21731758
[TBL] [Abstract][Full Text] [Related]
10. Recombinant murine beta interferon enhances resistance of mice to systemic Mycobacterium avium infection.
Denis M
Infect Immun; 1991 May; 59(5):1857-9. PubMed ID: 2019446
[TBL] [Abstract][Full Text] [Related]
11. Role of iron in the pathogenesis of Mycobacterium avium infection in mice.
Dhople AM; Ibanez MA; Poirier TC
Microbios; 1996; 87(351):77-87. PubMed ID: 9032957
[TBL] [Abstract][Full Text] [Related]
12. IL-10 neutralization augments mouse resistance to systemic Mycobacterium avium infections.
Denis M; Ghadirian E
J Immunol; 1993 Nov; 151(10):5425-30. PubMed ID: 8228235
[TBL] [Abstract][Full Text] [Related]
13. Tumour necrosis factor-alpha (TNF-alpha) in the host resistance to mycobacteria of distinct virulence.
Appelberg R; Sarmento A; Castro AG
Clin Exp Immunol; 1995 Aug; 101(2):308-13. PubMed ID: 7648714
[TBL] [Abstract][Full Text] [Related]
14. Mouse T cell clones against Mycobacterium avium: identification of clones that modify resistance against atypical mycobacteria infection.
Denis M
J Leukoc Biol; 1992 Jan; 51(1):7-12. PubMed ID: 1740647
[TBL] [Abstract][Full Text] [Related]
15. Modulation of Mycobacterium avium growth in vivo by cytokines: involvement of tumour necrosis factor in resistance to atypical mycobacteria.
Denis M
Clin Exp Immunol; 1991 Mar; 83(3):466-71. PubMed ID: 1900745
[TBL] [Abstract][Full Text] [Related]
16. Effector molecules of the host defence mechanism against Mycobacterium avium complex: the evidence showing that reactive oxygen intermediates, reactive nitrogen intermediates, and free fatty acids each alone are not decisive in expression of macrophage antimicrobial activity against the parasites.
Tomioka H; Sato K; Sano C; Akaki T; Shimizu T; Kajitani H; Saito H
Clin Exp Immunol; 1997 Aug; 109(2):248-54. PubMed ID: 9276519
[TBL] [Abstract][Full Text] [Related]
17. Host and bacterial factors control the Mycobacterium avium-induced chronic peritoneal granulocytosis in mice.
Appelberg R; Pedrosa JM; Silva MT
Clin Exp Immunol; 1991 Feb; 83(2):231-6. PubMed ID: 1993357
[TBL] [Abstract][Full Text] [Related]
18. Treatment with recombinant granulocyte colony-stimulating factor (Filgrastin) stimulates neutrophils and tissue macrophages and induces an effective non-specific response against Mycobacterium avium in mice.
Bermudez LE; Petrofsky M; Stevens P
Immunology; 1998 Jul; 94(3):297-303. PubMed ID: 9767410
[TBL] [Abstract][Full Text] [Related]
19. The role of tumor necrosis factor, interferon-gamma, transforming growth factor-beta, and nitric oxide in the expression of immunosuppressive functions of splenic macrophages induced by Mycobacterium avium complex infection.
Tomioka H; Sato K; Maw WW; Saito H
J Leukoc Biol; 1995 Dec; 58(6):704-12. PubMed ID: 7499969
[TBL] [Abstract][Full Text] [Related]
20. Defects in cell-mediated immunity affect chronic, but not innate, resistance of mice to Mycobacterium avium infection.
Doherty TM; Sher A
J Immunol; 1997 May; 158(10):4822-31. PubMed ID: 9144497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
